Advocacy intelligence hub — real-time data for patient organizations
Centre Cardiologique du Nord
Jian Chen — PHASE2
First Affiliated Hospital of Chengdu Medical College — PHASE2
Memorial Sloan Kettering Cancer Center — PHASE2
City of Hope Medical Center — PHASE1
Osijek University Hospital
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Neulasta
Amgen, Inc.
Neulasta
(Pegfilgrastim)Orphan drugstandardAmgen, Inc.
Leukocyte Growth Factor [EPC]
12.1 Mechanism of Action Pegfilgrastim products are colony-stimulating factors that act on hematopoietic cells by binding to specific cell surface rec...
Brenda Sandmaier
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
📍 SEATTLE, WA
David Maloney
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Amanda Olson
M.D. Anderson Cancer Center
Daniel J. DeAngelo, MD, PhD, OT
Dana-Farber Cancer Institute
📍 HIAWATHA, KS
A. John Barrett, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Robert Lowsky, MD, MD
Stanford Medical Center
📍 STANFORD, CA